vs
Side-by-side financial comparison of Hilltop Holdings Inc. (HTH) and Nutex Health, Inc. (NUTX). Click either name above to swap in a different company.
Hilltop Holdings Inc. is the larger business by last-quarter revenue ($300.5M vs $151.7M, roughly 2.0× Nutex Health, Inc.). Hilltop Holdings Inc. runs the higher net margin — 13.0% vs 7.8%, a 5.2% gap on every dollar of revenue. Over the past eight quarters, Nutex Health, Inc.'s revenue compounded faster (50.0% CAGR vs 0.6%).
Hilltop Holdings Inc. is a financial holding company based in Dallas, Texas. It offers financial products and banking services through three primary subsidiaries: PlainsCapital Bank, PrimeLending, and HilltopSecurities.
Nutex Health Inc. is an American for-profit health care company and operator of healthcare facilities headquartered in Houston, Texas.
HTH vs NUTX — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $300.5M | $151.7M |
| Net Profit | $39.0M | $11.8M |
| Gross Margin | — | 30.4% |
| Operating Margin | — | 20.4% |
| Net Margin | 13.0% | 7.8% |
| Revenue YoY | — | -41.1% |
| Net Profit YoY | -12.4% | -80.8% |
| EPS (diluted) | $0.64 | $2.34 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $300.5M | — | ||
| Q4 25 | $329.9M | $151.7M | ||
| Q3 25 | $330.2M | $267.8M | ||
| Q2 25 | $303.3M | $244.0M | ||
| Q1 25 | $318.5M | $211.8M | ||
| Q4 24 | $301.1M | $257.6M | ||
| Q3 24 | $305.5M | $78.8M | ||
| Q2 24 | $297.0M | $76.1M |
| Q1 26 | $39.0M | — | ||
| Q4 25 | $41.6M | $11.8M | ||
| Q3 25 | $45.8M | $55.4M | ||
| Q2 25 | $36.1M | $-17.7M | ||
| Q1 25 | $42.1M | $21.2M | ||
| Q4 24 | $35.5M | $61.6M | ||
| Q3 24 | $29.7M | $-8.8M | ||
| Q2 24 | $20.3M | $-364.0K |
| Q1 26 | — | — | ||
| Q4 25 | — | 30.4% | ||
| Q3 25 | — | 57.8% | ||
| Q2 25 | — | 51.2% | ||
| Q1 25 | — | 55.9% | ||
| Q4 24 | — | 55.0% | ||
| Q3 24 | — | 27.8% | ||
| Q2 24 | — | 29.7% |
| Q1 26 | — | — | ||
| Q4 25 | 16.1% | 20.4% | ||
| Q3 25 | 18.4% | 48.7% | ||
| Q2 25 | 16.3% | 13.8% | ||
| Q1 25 | 18.1% | 38.1% | ||
| Q4 24 | 14.7% | 44.4% | ||
| Q3 24 | 13.9% | 12.3% | ||
| Q2 24 | 10.0% | 7.0% |
| Q1 26 | 13.0% | — | ||
| Q4 25 | 12.6% | 7.8% | ||
| Q3 25 | 13.9% | 20.7% | ||
| Q2 25 | 11.9% | -7.3% | ||
| Q1 25 | 13.2% | 10.0% | ||
| Q4 24 | 11.8% | 23.9% | ||
| Q3 24 | 9.7% | -11.2% | ||
| Q2 24 | 6.8% | -0.5% |
| Q1 26 | $0.64 | — | ||
| Q4 25 | $0.68 | $2.34 | ||
| Q3 25 | $0.74 | $7.76 | ||
| Q2 25 | $0.57 | $-2.95 | ||
| Q1 25 | $0.65 | $3.33 | ||
| Q4 24 | $0.55 | $11.56 | ||
| Q3 24 | $0.46 | $-1.72 | ||
| Q2 24 | $0.31 | $-0.07 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $185.6M |
| Total DebtLower is stronger | $990.8M | — |
| Stockholders' EquityBook value | $2.2B | $329.4M |
| Total Assets | $15.7B | $918.5M |
| Debt / EquityLower = less leverage | 0.46× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | — | $185.6M | ||
| Q3 25 | — | $166.0M | ||
| Q2 25 | — | $96.7M | ||
| Q1 25 | — | $84.7M | ||
| Q4 24 | — | $40.6M | ||
| Q3 24 | — | $46.9M | ||
| Q2 24 | — | $40.8M |
| Q1 26 | $990.8M | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | $2.2B | — | ||
| Q4 25 | $2.2B | $329.4M | ||
| Q3 25 | $2.2B | $317.2M | ||
| Q2 25 | $2.2B | $235.3M | ||
| Q1 25 | $2.2B | $176.9M | ||
| Q4 24 | $2.2B | $132.4M | ||
| Q3 24 | $2.2B | $60.4M | ||
| Q2 24 | $2.1B | $62.7M |
| Q1 26 | $15.7B | — | ||
| Q4 25 | $15.8B | $918.5M | ||
| Q3 25 | $15.6B | $964.5M | ||
| Q2 25 | $15.4B | $841.0M | ||
| Q1 25 | $15.8B | $761.9M | ||
| Q4 24 | $16.3B | $655.3M | ||
| Q3 24 | $15.9B | $438.5M | ||
| Q2 24 | $15.6B | $422.4M |
| Q1 26 | 0.46× | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $70.4M |
| Free Cash FlowOCF − Capex | — | $69.0M |
| FCF MarginFCF / Revenue | — | 45.5% |
| Capex IntensityCapex / Revenue | — | 0.9% |
| Cash ConversionOCF / Net Profit | — | 5.95× |
| TTM Free Cash FlowTrailing 4 quarters | — | $245.6M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $-38.7M | $70.4M | ||
| Q3 25 | $273.0M | $99.5M | ||
| Q2 25 | $-234.6M | $27.3M | ||
| Q1 25 | $5.8M | $51.0M | ||
| Q4 24 | $273.9M | $54.0K | ||
| Q3 24 | $515.6M | $6.8M | ||
| Q2 24 | $-435.3M | $13.3M |
| Q1 26 | — | — | ||
| Q4 25 | $-55.5M | $69.0M | ||
| Q3 25 | $271.0M | $99.2M | ||
| Q2 25 | $-234.6M | $26.5M | ||
| Q1 25 | $5.0M | $50.9M | ||
| Q4 24 | $266.8M | $-341.0K | ||
| Q3 24 | $513.8M | $6.2M | ||
| Q2 24 | $-437.3M | $12.7M |
| Q1 26 | — | — | ||
| Q4 25 | -16.8% | 45.5% | ||
| Q3 25 | 82.1% | 37.0% | ||
| Q2 25 | -77.4% | 10.9% | ||
| Q1 25 | 1.6% | 24.0% | ||
| Q4 24 | 88.6% | -0.1% | ||
| Q3 24 | 168.2% | 7.8% | ||
| Q2 24 | -147.2% | 16.7% |
| Q1 26 | — | — | ||
| Q4 25 | 5.1% | 0.9% | ||
| Q3 25 | 0.6% | 0.1% | ||
| Q2 25 | 0.0% | 0.3% | ||
| Q1 25 | 0.3% | 0.0% | ||
| Q4 24 | 2.4% | 0.2% | ||
| Q3 24 | 0.6% | 0.8% | ||
| Q2 24 | 0.7% | 0.7% |
| Q1 26 | — | — | ||
| Q4 25 | -0.93× | 5.95× | ||
| Q3 25 | 5.96× | 1.80× | ||
| Q2 25 | -6.50× | — | ||
| Q1 25 | 0.14× | 2.40× | ||
| Q4 24 | 7.71× | 0.00× | ||
| Q3 24 | 17.36× | — | ||
| Q2 24 | -21.41× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
HTH
| Noninterest Income | $188.4M | 63% |
| Net Interest Income | $112.1M | 37% |
NUTX
| Hospital Division | $143.7M | 95% |
| Population Health Management Division | $8.0M | 5% |
